Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division
John Replogle(Massachusetts Institute of Technology), Angelika Amon(Massachusetts Institute of Technology), Anthony Letai(Dana-Farber Cancer Institute), Stephen J. Lippard(IIT@MIT), Uri Ben‐David(Tel Aviv University), Jason M. Sheltzer(Yale University), Jeremy Ryan(Dana-Farber Cancer Institute), Mariana Villalobos-Ortiz(Dana-Farber Cancer Institute), James M. McFarland(Broad Institute), Adrianna E. Amaro(Massachusetts Institute of Technology), Ömer Yılmaz(Ondokuz Mayıs University), Wen Zhou(Massachusetts Institute of Technology)
Cited by 116
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
|Chemical Reviews|2016|2.4k
A single-cell survey of the small intestinal epithelium
|Nature|2017|1.9k